ArticleCancer research communications2026
Assessing the Feasibility of Community-Based Colorectal Cancer Screening in Pune, India.
Article in Cancer research communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The colorectal cancer rates in India are lower than in other Southeast Asian countries, but there is an increasing trend in incidence as well as mortality. We are reporting the results of a large community-based colorectal cancer screening project implemented through a house-to-house survey. Consenting men and women of ages 50 to 75 years were informed about the purpose of the study and the benefits of colorectal cancer screening. They were educated on how to collect stool sample for occult blood test in a sample collection tube. Health visitors collected the stool sample from the study participants on the next day. Samples were tested with CANCHECK-FOBT, which is Conformite Europeenne-approved and is a rapid, qualitative, two-site sandwich immunoassay for the detection of immunochemical fecal occult blood (iFOB) concentration in human feces. Participants with a positive iFOB test (iFOBT) result underwent colonoscopy as an outpatient procedure at the gastroenterologist's clinic. A total of 5,003 participants provided consent, and 4,352 (86.98%) provided the stool sample. iFOBT was positive among 70/4,352 (1.61%) participants, of whom 31 (44.92%) completed the colonoscopy procedure. Five participants were diagnosed with adenomatous polyps, and one participant had colorectal cancer. The detection rate of histologically confirmed colorectal cancer was 0.23 and that of adenomatous polyp was 1.15 per 1,000 screened persons. Although the screen positivity and adenomatous polyps and colorectal cancer detection rates in our study are much lower than the in neighboring Southeast Asian countries, these findings highlight the importance of investing in preventive healthcare in India. SIGNIFICANCE: This is the first community-based colorectal cancer screening study from India that suggests the feasibility of colorectal cancer screening. There is an urgent need for investment in prevention of common cancers in the Indian population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.